Table: begin end state 1 21 cytoplasmic 22 40 transmembrane 41 45 non-cytoplasmic 46 65 transmembrane 66 100 cytoplasmic 101 123 transmembrane 124 128 non-cytoplasmic 129 147 transmembrane 148 156 cytoplasmic 157 178 transmembrane 179 197 non-cytoplasmic 198 222 transmembrane 223 242 cytoplasmic 243 264 transmembrane 265 282 non-cytoplasmic 283 302 transmembrane 303 333 cytoplasmic 334 356 transmembrane 357 361 non-cytoplasmic 362 384 transmembrane 385 403 cytoplasmic 404 424 transmembrane 425 429 non-cytoplasmic 430 448 transmembrane 449 465 cytoplasmic
Input: >RR42_RS33495 FitnessBrowser__Cup4G11:RR42_RS33495 MVPNASDNTDATLKRGLKNRHIQLIALGGAIGTGLFLGIAQTIKMAGPSVLLGYAVAGII AFFIMRQLGEMVVDEPVAGSFSHFANKYCGSFAGFMSGWNYWVLYILVSMAELSAVGIYV QYWWPHIPTWASALGFFLLINAINLTSVKSFGEMEFWFSIVKVLAIVGMIVFGGYLLASG TAGPQASVSNLWQHGGFFPNGISGLVMAMAVIMFSFGGLELVGITAAEADEPEKTIPKAT NQVIYRILIFYVGALGVLLSLYPWEKVVTGGSPFVLIFHAMNSDIVATVLNAVVLTAALS VYNSGVYCNSRMLFGLAKQGNAPKALLKVNKRGIPLAALGVSALATAACVVINYFMPGEA FELLMGLVVSALIINWAMISIIHLKFRRDKRAAGQETRFKSLGYPLTNYVCLAFLAGILY VMYLTPGLRISVYLIPAWLAVLGLSYRLRQKQKRAEPALPERVSA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server